Our top pick for
Dada Nexus Limited is an internet retail business based in the US. Dada Nexus shares (DADA) are listed on the NASDAQ and all prices are listed in US Dollars. Dada Nexus employs 2,440 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$22.82|
|52-week range||$17.57 - $61.27|
|50-day moving average||$21.41|
|200-day moving average||$23.84|
|Wall St. target price||$39.84|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-1.81|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-19)||0.09%|
|1 month (2021-09-24)||13.87%|
|3 months (2021-07-26)||8.72%|
|6 months (2021-04-26)||-10.96%|
|1 year (2020-10-26)||-30.28%|
|2 years (2019-10-22)||N/A|
|3 years (2018-10-22)||N/A|
|5 years (2016-10-22)||N/A|
|Revenue TTM||$6.5 billion|
|Gross profit TTM||$1 billion|
|Return on assets TTM||-20.9%|
|Return on equity TTM||-42.06%|
|Market capitalisation||$5.4 billion|
TTM: trailing 12 months
There are currently 3.4 million Dada Nexus shares held short by investors – that's known as Dada Nexus's "short interest". This figure is 3.5% down from 3.5 million last month.
There are a few different ways that this level of interest in shorting Dada Nexus shares can be evaluated.
Dada Nexus's "short interest ratio" (SIR) is the quantity of Dada Nexus shares currently shorted divided by the average quantity of Dada Nexus shares traded daily (recently around 1.3 million). Dada Nexus's SIR currently stands at 2.7. In other words for every 100,000 Dada Nexus shares traded daily on the market, roughly 2700 shares are currently held short.
However Dada Nexus's short interest can also be evaluated against the total number of Dada Nexus shares, or, against the total number of tradable Dada Nexus shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Dada Nexus's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Dada Nexus shares in existence, roughly 10 shares are currently held short) or 0.0513% of the tradable shares (for every 100,000 tradable Dada Nexus shares, roughly 51 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Dada Nexus.
Find out more about how you can short Dada Nexus stock.
We're not expecting Dada Nexus to pay a dividend over the next 12 months.
Dada Nexus Limited operates platform of local on-demand retail and delivery in China. It operates JDDJ, a local on-demand retail platform for consumers, retailers, and brand owners; and Dada Now, a local on-demand delivery platform for merchants and individual senders in various industries and product categories. The company was incorporated in 2014 and is headquartered in Shanghai, the People's Republic of China. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.